J. Ma et al., METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM, DIETARY INTERACTIONS, AND RISK OF COLORECTAL-CANCER, Cancer research, 57(6), 1997, pp. 1098-1102
Folate derivatives are important in experimental colorectal carcinogen
esis; low folate intake, particularly with substantial alcohol intake,
is associated with increased risk. The enzyme 5,10-methylenetetrahydr
ofolate reductase (MTHFR) catalyzes the conversion of 5,10-methylenete
trahydrofolate, required for purine and thymidine syntheses, to 5-meth
yltetrahydrofolate, the primary circulatory form of folate necessary f
or methionine synthesis, A common mutation (677C-->T) in MTHFR reduces
enzyme activity, leading to lower levels of 5-methyltetrahydrofolate.
To evaluate the role of folate metabolism in human carcinogenesis, we
examined the associations of MTHFR mutation, plasma folate levels, an
d their interaction with risk of colon cancer. We also examined the in
teraction between genotype and alcohol intake. We used a nested case-c
ontrol design within the Physicians' Health Study, Participants were a
ges 40-84 at baseline when alcohol intake was ascertained and blood sa
mples were drawn, During 12 years of follow-up, we identified 202 colo
rectal cancer cases and matched them to 326 cancer-free controls by ag
e and smoking status. We genotyped for the MTHFR polymorphism and meas
ured plasma folate levels. Men with the homozygous mutation (15% in co
ntrols) had half the risk of colorectal cancer [odds ratio (OR), 0.49;
95% confidence interval (CI), 0.27-0.87] compared with the homozygous
normal or heterozygous genotypes. Overall, we observed a marginal sig
nificant increased risk of colorectal cancer (OR, 1.78; 95% CI, 0.93-3
.42) among those whose plasma folate levels indicated deficiency (< 3
ng/ml) compared with men with adequate folate levels, Among men with a
dequate folate levels, we observed a S-fold decrease in risk (OR, 0.32
; 95% CI, 0.15-0.68) among men with the homozygous mutation compared w
ith those with the homozygous normal or heterozygous genotypes. Howeve
r, the protection due to the mutation was absent in men with folate de
ficiency, In men with the homozygous normal genotype who drank little
or no alcohol as reference, those with the homozygous mutation who dra
nk little or no alcohol had an 8-fold decrease in risk (OR, 0.12; 95%
CI, 0.03-0.57), and for moderate drinkers, a 2-fold decrease in risk (
OR, 0.42; 95% CI, 0.15-1.20); no decrease in risk was seen in those dr
inking 1 or more drinks/day. Our findings provide support for an impor
tant role of folate metabolism in colon carcinogenesis. In particular,
these results suggest that the 677C-->T mutation in MTHFR reduces col
on cancer risk, perhaps by increasing 5,10-methylenetetrahydrofolate l
evels for DNA synthesis, but that low folate intake or high alcohol co
nsumption may negate some of the protective effect.